Multidisciplinary approaches to the management of malignant pleural effusions: a guide for the clinician

被引:3
作者
Banka, Radhika [1 ]
George, Vineeth [1 ]
Rahman, Najib M. [1 ,2 ,3 ]
机构
[1] Oxford Univ Hosp NHS Trust, Oxford Ctr Resp Med, Oxford, England
[2] Univ Oxford, Churchill Hosp, Resp Trials Unit, Oxford, England
[3] Univ Oxford, NIHR Oxford Biomed Res Ctr, Oxford, England
关键词
Malignant; pleural effusion; management; pleurodesis; indwelling pleural catheter; thoracoscopy; CHEST TUBE SIZE; TALC PLEURODESIS; PROGNOSTIC-SIGNIFICANCE; CATHETER; EFFICACY; SURVIVAL; POUDRAGE; FLUID; PLEURECTOMY; QUESTIONS;
D O I
10.1080/17476348.2020.1793672
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction Malignant pleural effusion (MPE) is a complication of advanced cancer, associated with significant mortality and morbidity. This entity is commonly treated by respiratory physicians, oncologists, and thoracic surgeons. There have been various randomized clinical trials assessing the relative merits of chest drain pleurodesis, indwelling pleural catheters, treatment of septated MPEs, the use of thoracoscopy and pleurodesis and pleurodesis through IPCs in the past decade which have addressed some key areas in the management of MPEs, with an increasing focus on patient related outcome. Areas covered In this review, we examine and review the literature for management strategies for MPEs and discuss future directions. A detailed search of scientific literature and clinical trial registries published in the past two decades was undertaken. Expert opinion Tremendous progress has been made in management of MPE in the past decade and current strategy involves patient preference along with local expertise that is available.
引用
收藏
页码:1009 / 1018
页数:10
相关论文
共 76 条
  • [1] [Anonymous], MY PLEURAL EFFUSION
  • [2] [Anonymous], 2019, JAMA
  • [3] Management of malignant pleural effusions
    Antony, VB
    Loddenkemper, R
    Astoul, P
    Boutin, C
    Goldstraw, P
    Hott, J
    Panadero, FR
    Sahn, SA
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (05) : 1987 - 2001
  • [4] BTS guidelines for the management of malignant pleural effusions
    Antunes, G
    Neville, E
    Duffy, J
    Ali, N
    [J]. THORAX, 2003, 58 : II29 - II38
  • [5] BREAST-CANCER COMPLICATED BY PLEURAL EFFUSION - PATIENT CHARACTERISTICS AND RESULTS OF SURGICAL-MANAGEMENT
    APFFELSTAEDT, JP
    VANZYL, JA
    MULLER, AGS
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 1995, 58 (03) : 173 - 175
  • [6] Small Particle-Size Talc Is Associated with Poor Outcome and Increased Inflammation in Thoracoscopic Pleurodesis
    Arellano-Orden, Elena
    Romero-Falcon, Auxiliadora
    Juan, Jose Martin
    Ocana Jurado, Manuel
    Rodriguez-Panadero, Francisco
    Montes-Worboys, Ana
    [J]. RESPIRATION, 2013, 86 (03) : 201 - 209
  • [7] The Hospital and Patient Burden of Indwelling Pleural Catheters: A Retrospective Case Series of 210 Indwelling Pleural Catheter Insertions
    Asciak, Rachelle
    Hallifax, Robert John
    Mercer, Rachel Mary
    Hassan, Maged
    Wigston, Charlotte
    Wrightson, John M.
    Psallidas, Ioannis
    Rahman, Najib Mahboob
    [J]. RESPIRATION, 2019, 97 (01) : 70 - 77
  • [8] Novel pleural-bladder pump in malignant pleural effusions: from animal model to man
    Astoul, Philippe
    Laroumagne, Sophie
    Capel, Jeroen
    Maskell, Nicholas A.
    [J]. THORAX, 2020, 75 (05) : 432 - 434
  • [9] Banka R, 2018, CURR PULMONOL REP, V7, P1, DOI 10.1007/s13665-018-0194-3
  • [10] The Malignant Pleural Effusion as a Model to Investigate Intratumoral Heterogeneity in Lung Cancer
    Basak, Saroj K.
    Veena, Mysore S.
    Oh, Scott
    Huang, Ge
    Srivatsan, Eri
    Min Huang
    Sharma, Sherven
    Batra, Raj K.
    [J]. PLOS ONE, 2009, 4 (06):